Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

151 та иш

Иш: Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications

  1. MicroRNA as a Potential Therapeutic Molecule in Cancer

    Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn

    Шарҳ мақола20225 иқтибос
    ABI

  2. Unique features of long non-coding RNA biogenesis and function

    Jeffrey J. Quinn, Howard Y. Chang

    Шарҳ мақола20154 иқтибос
    ABI

  3. miRNA: A Promising Therapeutic Target in Cancer

    Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid +2

    Шарҳ мақола20224 иқтибос
    ABI

  4. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics

    Takayuki Nojima, Nicholas Proudfoot

    Шарҳ мақола20223 иқтибос
    ABI

  5. miR‐146a‐5p: Expression, regulation, and functions in cancer

    Joseph R. Iacona, Carol S. Lutz

    Шарҳ мақола20193 иқтибос
    ABI

  6. Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer

    Shiva Najjary, Reza Mohammadzadeh, Ahad Mokhtarzadeh +3

    Шарҳ мақола20203 иқтибос
    ABI

  7. The comprehensive landscape of miR-34a in cancer research

    Sijing Li, Xiaohui Wei, Jinyong He +6

    Шарҳ мақола20213 иқтибос
    ABI

  8. RETRACTED ARTICLE: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

    Jing Sun, Xin Cai, Mingo M. H. Yung +14

    Мақола20183 иқтибос
    ABI

  9. Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function

    Junfeng Wang, Quanyi Wang, Yinan Guan +10

    Мақола20222 иқтибос
    ABI

  10. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling

    Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam +11

    Шарҳ мақола20222 иқтибос
    ABI

  11. MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence

    Malathi Ramalinga, Arpita Roy, Anvesha Srivastava +5

    Мақола20152 иқтибос
    ABI

  12. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway

    Qingqiang Dai, Tianqi Zhang, Jiaomeng Pan +1

    Мақола20202 иқтибос
    ABI

  13. EZH2: a novel target for cancer treatment

    Ran Duan, Wenfang Du, Weijian Guo

    Шарҳ мақола20202 иқтибос
    ABI

  14. Function of microRNA‑124 in the pathogenesis of cancer (Review)

    Yuchen Liu, Yipin Yang, Xinyi Wang +9

    Шарҳ мақола20232 иқтибос
    ABI

  15. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers

    Ilaria Cavallari, Francesco Ciccarese, Evgeniya Sharova +5

    Шарҳ мақола20212 иқтибос
    ABI

  16. Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

    Dejuan Kong, Elisabeth I. Heath, Wei Chen +13

    Мақола20122 иқтибос
    ABI

  17. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1

    Jun Zhang, Shuai Guo, Haiyan Piao +6

    Мақола20192 иқтибос
    ABI

  18. EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies

    Ivana Samaržija, Marko Tomljanović, Renata Novak Kujundžić +1

    Шарҳ мақола20222 иқтибос
    ABI

  19. Ezh2 Inhibition by Tazemetostat: Mechanisms of Action, Safety and Efficacy in Relapsed/refractory Follicular Lymphoma

    Edith Julia, Gilles Salles

    Мақола20212 иқтибос
    ABI

  20. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function

    Yi Zhao, Changjiang Feng, Yunjing Li +2

    Мақола20192 иқтибос
    ABI

  21. Decoding hepatocarcinogenesis from a noncoding RNAs perspective

    Mostafa K. Abd El‐Aziz, Alyaa Dawoud, Caroline Joseph Kiriacos +3

    Шарҳ мақола20232 иқтибос
    ABI

  22. MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2

    Juan Lü, Ming‐Liang He, Lu Wang +8

    Мақола20112 иқтибос
    ABI

  23. EZH2 couples pancreatic regeneration to neoplastic progression

    Jon Mallen‐St. Clair, Rengin G. Soydaner-Azeloglu, Kyoung Eun Lee +7

    Мақола20122 иқтибос
    ABI

  24. Loss of <i>Ezh2</i> synergizes with <i>JAK2</i> -V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis

    Takafumi Shimizu, Lucia Kubovčáková, Ronny Nienhold +11

    Мақола20162 иқтибос
    ABI

  25. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target

    Yiping Wen, Jing Cai, Yaya Hou +2

    Шарҳ мақола20172 иқтибос
    ABI